Back to Search Start Over

Beijing Wantai plans large Phase III trial of nasal spray COVID-19 vaccine candidate

Source :
M2 Pharma. September 23, 2021
Publication Year :
2021

Abstract

M2 PHARMA-September 23, 2021-Beijing Wantai plans large Phase III trial of nasal spray COVID-19 vaccine candidate (C)2021 M2 COMMUNICATIONS Beijing Wantai Biological Pharmacy Enterprise (SHA:603392), a Chinese vaccine developer and [...]

Subjects

Subjects :
Biological products industry -- Product development -- Planning
Respiratory agents
Clinical trials
Vaccines -- Product development -- Planning
Company business planning
Chemistry

Details

Language :
English
Database :
Gale General OneFile
Journal :
M2 Pharma
Publication Type :
News
Accession number :
edsgcl.676479281

Tools

Authors Abstract Subjects Details